

Alamar Biosciences (NASDAQ:ALMR) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Alamar Biosciences (NASDAQ:ALMR) through any online brokerage.
Other companies in Alamar Biosciences’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Alamar Biosciences has a consensus price target of $34.50.
The stock price for Alamar Biosciences (NASDAQ: ALMR) is $26.76 last updated November 5, 2026 at 2:22 PM EST.
There are no upcoming dividends for Alamar Biosciences.
Alamar Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Alamar Biosciences.
Alamar Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling...